Form 8-K - Current report:
SEC Accession No. 0001571049-16-019587
Filing Date
2016-11-07
Accepted
2016-11-07 16:37:43
Documents
3
Period of Report
2016-11-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1602689_8k.htm 8-K 17898
2 EXHIBIT 99.1 t1602689_ex99-1.htm EX-99.1 3065
3 GRAPHIC t1602689_ex99-1logo.jpg GRAPHIC 18629
  Complete submission text file 0001571049-16-019587.txt   48060
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 161978629
SIC: 2834 Pharmaceutical Preparations